Zobrazeno 1 - 10
of 107
pro vyhledávání: '"Kezhen Fei"'
Autor:
Nita Vangeepuram, Kezhen Fei, Crispin Goytia, Devin Madden, Giselle Corbie-Smith, Carol R. Horowitz
Publikováno v:
Journal of Participatory Research Methods, Vol 4, Iss 2 (2023)
Employment of community-based participatory research (CBPR) strategies has helped address limitations of traditional research approaches, but we still do not have a full understanding of how study teams successfully conduct research with populations
Externí odkaz:
https://doaj.org/article/1a4674b377204b659b27d4fa7b2112e8
Autor:
Emily J. Gallagher, Kezhen Fei, Sheldon M. Feldman, Elisa Port, Neil B. Friedman, Susan K. Boolbol, Brigid Killelea, Melissa Pilewskie, Lydia Choi, Tari King, Anupma Nayak, Rebeca Franco, Daliz Cruz, Irini M. Antoniou, Derek LeRoith, Nina A. Bickell
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-10 (2020)
Abstract Background Racial disparities in breast cancer survival between Black and White women persist across all stages of breast cancer. The metabolic syndrome (MetS) of insulin resistance disproportionately affects more Black than White women. It
Externí odkaz:
https://doaj.org/article/dbb802256d2542bdaa3a9fa52e21db53
Publikováno v:
International Journal of Breast Cancer, Vol 2013 (2013)
Oncotype DX, a 21-gene-array analysis, can guide chemotherapy treatment decisions for women with ER+ tumors. Of 225 ER+ women participating in a patient assistance trial, 23% underwent Oncotype DX testing: 31% of whites, 21% of blacks, and 14% of His
Externí odkaz:
https://doaj.org/article/7908eb6b3c724acdaac9bd09cd8291a4
Publikováno v:
International Journal of Epidemiology.
Autor:
Nicole T. Gordon, Neil B. Friedman, Giampaolo Greco, Susan K. Boolbol, Sheldon Feldman, Bridgid Killilea, Lydia Choi, Melissa Pilewskie, Elisa Port, Emily J. Gallagher, J. Jaime Alberty-Oller, Derek LeRoith, Amy Tiersten, Kezhen Fei, Nina A. Bickell
Publikováno v:
Annals of Surgical Oncology. 28:5941-5947
Black women with breast cancer have a worse overall survival compared with White women; however, no difference in Oncotype DX™ (ODX) recurrence scores has been observed to explain this health disparity. Black women are also disproportionately affec
Autor:
Timothy A. Yap, Siddhartha Yadav, Benjamin Herzberg, Benedito A. Carneiro, Elisa Fontana, Martin Højgaard, Michael J. Pishvaian, Ruth Plummer, Theresa L. Werner, Vaibhav Sahai, Stephanie Lheureux, Elizabeth K. Lee, Niharika B. Mettu, Gregory M. Cote, Joseph D. Schonhoft, Victoria Rimkunas, Ian M. Silverman, Marisa Wainszelbaum, Gerson Peltz, Adrian J. Fretland, Kezhen Fei, Danielle Ulanet, Insil Kim, Maria Koehler, Ezra Rosen, Michael Cecchini
Publikováno v:
Cancer Research. 83:CT018-CT018
Introduction: ATRi and PARPi combinations kill tumor cells via synergistic modulation of complementary DDR pathways but clinical utility is limited by overlapping toxicities. A genome-wide CRISPR-Cas9 screen identified DDR alterations that sensitize
Autor:
Girish N. Nadkarni, Kezhen Fei, Michelle A. Ramos, Diane Hauser, Emilia Bagiella, Stephen B. Ellis, Saskia Sanderson, Stuart A. Scott, Tatiana Sabin, Ebony Madden, Richard Cooper, Martin Pollak, Neil Calman, Erwin P. Bottinger, Carol R. Horowitz
Publikováno v:
JAMA network open. 5(3)
Risk variants in the apolipoprotein L1 (APOL1 [OMIM 603743]) gene on chromosome 22 are common in individuals of West African ancestry and confer increased risk of kidney failure for people with African ancestry and hypertension. Whether disclosing AP
Autor:
Susan Beane, Tom Wang, Rashi Kumar, Amy Balbierz, Kezhen Fei, Zainab N Ahmed, José A. Pagán, Elizabeth A. Howell
Publikováno v:
Am J Public Health
A health care system and a Medicaid payer partnered to develop an educational intervention and payment redesign program to improve timely postpartum visits for low-income, high-risk mothers in New York City between April 2015 and October 2016. The ti
Autor:
Xiaoyu Song, Valerie McGuire, Daniel L. Rubin, Stacey E. Alexeeff, Weiva Sieh, Laurel A. Habel, Russell B. McBride, Luana Acton, Kezhen Fei, Joseph H. Rothstein, Alice S. Whittemore, Jafi A. Lipson, Lori C. Sakoda, Rhea Y. Liang, Ninah Achacoso, Martin J. Yaffe
Publikováno v:
Cancer Epidemiol Biomarkers Prev
Background: Percent density (PD) is a strong risk factor for breast cancer that is potentially modifiable by lifestyle factors. PD is a composite of the dense (DA) and nondense (NDA) areas of a mammogram, representing predominantly fibroglandular or
Autor:
Laurel A. Habel, Stacey E. Alexeeff, Ninah Achacoso, Xiaoyu Song, Lori C. Sakoda, Weiva Sieh, Valerie McGuire, Russell B. McBride, Kezhen Fei, Luana Acton, Alice S. Whittemore, Rhea Y. Liang, Jafi A. Lipson, Martin J. Yaffe, Daniel L. Rubin, Joseph H. Rothstein
Publikováno v:
Cancer Research. 80:P2-08
Background: High percent density (PD) is common and is among the strongest risk factors for breast cancer. The prevalence of heterogeneously dense or extremely dense breasts is between 40% to 60% of screening age women, and is estimated to account fo